UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

 

SCHEDULE 14F-1

 

INFORMATION STATEMENT

 

Pursuant to Section 14(F) of the Securities Exchange Act of 1934

and Rule 14f-1 thereunder

 

 

BESPOKE EXTRACTS, INC.

(Exact name of registrant as specified in its charter)

 

000-52759

(Commission File Number)

 

Nevada   20-4743354

(State or other jurisdiction of

incorporation or organization)

  (I.R.S. Employer
Identification No.)

 

323 Sunny Isles Blvd., Suite 700

Sunny Isles, Florida, 33160

(Address of principal executive offices)

 

(855) 633-3738

(Registrant’s telephone number)

 

 

 

 

 

BESPOKE EXTRACTS, INC.

323 Sunny Isles Blvd., Suite 700

Sunny Isles, Florida, 33160

 

INFORMATION STATEMENT PURSUANT TO

SECTION 14(f) OF

THE SECURITIES EXCHANGE ACT OF 1934

AND RULE 14f-1 THEREUNDER

 

NOTICE OF CHANGE IN MAJORITY OF THE BOARD OF DIRECTORS 

 

May 1, 2020

 

INTRODUCTION

 

This Information Statement is being mailed to shareholders of record as of May 1, 2020 of the shares of common stock of Bespoke Extracts, Inc., a Nevada corporation (the “Company”), in accordance with the requirements of Section 14(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 14f-1 promulgated thereunder. Section 14(f) of the Exchange Act and Rule 14f-1 require the mailing to our shareholders of record of the information set forth in this Information Statement at least 10 days prior to the date a change in a majority of our directors occurs (otherwise than at a meeting of our shareholders). Accordingly, the change in a majority of our directors described herein will not occur until at least 10 days following the mailing of this Information Statement. 

 

As used in this Information Statement, unless the context otherwise requires or where otherwise indicated, “we”, “our”, “us”, the “Company” and similar expressions refer to Bespoke Extracts, Inc.

 

THIS INFORMATION STATEMENT IS BEING PROVIDED SOLELY FOR INFORMATIONAL PURPOSES AND NOT IN CONNECTION WITH ANY VOTE OF THE SHAREHOLDERS OF BESPOKE EXTRACTS, INC.

 

NO PROXIES ARE BEING SOLICITED AND YOU ARE NOT REQUESTED TO SEND A PROXY OR TAKE ANY OTHER ACTION.

 

 

 

CHANGE IN DIRECTORS

 

On April 21, 2020, Niquana Noel resigned as the Company’s president, chief executive officer and chief financial officer and Danil Pollack was appointed as the Company’s president, chief executive officer and chief financial officer. Ms. Noel will resign as the Company’s director, and Mr. Pollack will be appointed as the Company’s director, 10 days following the mailing of this Information Statement. In connection with Ms. Noel’s resignation and Mr. Pollack’s appointment, Ms. Noel sold 1 share of Series C Preferred Stock of the Company (which provides the holder with 51% of the voting power of the Company’s stockholders) to Mr. Pollack for $24,000, and the Company entered into an employment agreement with Mr. Pollack, pursuant to which he was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock with an exercise price of $0.001 per share.

 

VOTING SECURITIES

 

As of the date of this Information Statement, the Company is authorized to issue 800,000,000 shares of common stock, $0.001 par value per share and 50,000,000 shares of preferred stock, par value $0.001 per share. As of May 1, 2020, 110,389,621 shares of common stock and 1 share of Series C Preferred Stock were issued and outstanding, respectively. Each share of Company common stock entitles the holder thereof to one vote. The Series C Preferred Stock entitles the holder to 51% of the voting power of the Company’s stockholders.

 

SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT

 

As of May 1, 2020 we had 110,389,621 shares of common stock issued and outstanding. The following table sets forth information known to us relating to the beneficial ownership of such shares as of such date by:

 

  each person who is known by us to be the beneficial owner of more than 5% of our outstanding voting stock;

 

  each director;

 

  each named executive officer; and

 

  all named officers and directors as a group.

 

Unless otherwise indicated, the business address of each person listed is care of Bespoke Extracts, Inc., at 323 Sunny Isles Blvd., Suite 700, Sunny Isles, Florida 33160. The percentages in the table have been calculated on the basis of treating as outstanding for a particular person, all shares of our common stock outstanding on that date and all shares of our common stock issuable to that holder in the event of exercise of outstanding options, warrants, rights or conversion privileges owned by that person at that date which are exercisable within 60 days of May 1, 2020. Except as otherwise indicated, the persons listed below have sole voting and investment power with respect to all shares of our common stock owned by them.

 

Name of Beneficial Owner   Amount of Beneficial Ownership     Percent of Class  
Executive Officers and Directors:                
Danil Pollack     100,000,000 (1)     47.5 %
Niquana Noel     20,000,000       18.1 %
Officers and Directors as a group (2 persons):     120,000,000       57.0 %
5% Holders:                
McGlothlin Holdings, Ltd. (2)     14,562,667       6.9 %
Ronald Smith (3)     20,833,333       18.9 %

  

(1) Represents shares issuable upon exercise of right to purchase. Mr. Pollack also owns 1 outstanding share of Series C Preferred Stock.

(2) McGlothlin Holdings, Ltd.’s address is PO Box 590, Luling, Texas, 78649, and its control person is Stan McGlothlin.  

(3) Mr. Smith’s address is 9239 Carpenter Rd., Eden, NY 14057.

 

1

 

 

 

DIRECTORS AND EXECUTIVE OFFICERS

 

Current Officers and Directors of the Company

 

The following discussion sets forth information regarding our current executive officers and directors.

 

Name   Age   Title
Niquana Noel   39   Director
Danil Pollack   32   President, Chief Executive Officer, Chief Financial Officer

  

Niquana Noel. Ms. Noel served as the Company’s president, chief executive officer and chief financial officer from October 2018 until April 2020, and has served as a director since October 2018. Ms. Noel previously served as operations manager at the Company. Ms. Noel has served as chief operating officer of Coro Global Inc. (“Coro”) since May 18, 2018 and as a director of Coro since August 2013. She served as Coro’s chief executive officer and president from January 2014 to May 2018. Prior to serving in that capacity, Ms. Noel served as Coro’s operations manager from 2008. Prior to joining Coro, Ms. Noel was the Executive Assistant to a Florida-based serial entrepreneur who had business interests ranging from the ownership and operation of cemeteries in Maryland, Virginia and Florida to the ownership and operation of exotic, high performance car dealerships and auto accessory businesses. Ms. Noel’s operational experience qualifies her to serve on the Company’s board of directors.

 

Danil Pollack. Mr. Pollack was appointed president, chief executive officer and chief financial officer of the Company on April 21, 2020. Prior to the joining the Company, Mr. Pollack oversaw sales and marketing at 2Marketing as Project Manager, a PPC (pay per click), SEO and social media and inbound marketing firm in Toronto, from 2017. In addition, he worked as a lead videographer and editor at YP Media Productions, a creative film production agency which he co-founded in 2010. Between 2010 and 2013, Mr. Pollack also served as Vice President of Operations at Auto Ad, Inc., a full service infomercial production agency specializing in the auto dealership market. Fluent in three languages, Mr. Pollack attended the Toronto Film School, as well as Senaca College - York, where he studied computer system technology.

 

Officers and Directors Following the Company Meeting its Information Requirements under the Exchange Act

 

Danil Pollack will serve as the Company’s director, president, chief executive officer, and chief financial officer, following the Company meeting its information obligations under the Exchange Act.

 

Background information with respect to Mr. Pollack is in the “Current Officers and Directors of the Company” section above.

 

Terms of Office

 

Our directors are appointed for one year terms in accordance with our charter documents and hold office until the earlier of (i) the next annual meeting of our shareholders, (ii) until they are removed from the board or (iii) until they resign.

 

Family Relationships

 

None.

 

2

 

 

Legal Proceedings

 

Involvement in Certain Legal Proceedings

 

During the past ten years, none of our current directors or executive officers has been:

 

  the subject of any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
  convicted in a criminal proceeding or is subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
  subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or any Federal or State authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities;
  found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law.
  the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of (a) any Federal or State securities or commodities law or regulation; (b) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or (c) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
  the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Change of Control Arrangements

 

We have no pension or compensatory plans or other arrangements which provide for compensation to our directors or officers in the event of a change in our control. There are no arrangements known to us the operation of which may at a later date result in a change in control of our company. 

 

TRANSACTIONS WITH RELATED PERSONS

  

On September 18, 2017, the Company issued a $180,000 convertible debenture with an original issue discount of $60,000 to Alneil Associates (“Alneil”), which was then a greater than 5% stockholder. The note had a 0% interest rate and a term of two years. In connection with the note, the Company issued to Alneil an aggregate of 900,000 shares of common stock and 300,000 warrants to purchase common stock. The debenture and warrants were subsequently exchanged for common stock of the Company, as described below.

 

On December 13, 2017, the Company issued a $120,000 convertible debenture to McGlothlin Holdings, Ltd. (“McGlothlin), a greater than 5% stockholder, with an original issue discount of $20,000. The debenture had a 0% interest rate and a term of one year. The conversion price of the outstanding balance was the lesser of $3.00 or 40% of the volume weighted average price of the last 30 days at date of conversion; not to be less than $1.00. In connection with the debenture, the Company issued to McGlothlin an aggregate of 200,000 shares of common stock and 100,000 warrants to purchase common stock. The debenture and warrants were subsequently exchanged for common stock of the Company, as described below.

 

During the year ended August 31, 2018, the Company had sales of $3,975 to the spouse of Stan McGlothin, who is the owner of McGlothlin.

 

On April 22, 2019, the Company entered into an exchange agreement with McGlothlin. Pursuant to the exchange agreement, McGlothlin exchanged convertible debentures of the Company, in the original principal amounts of $540,000 and $120,000, respectively, and 1,000,000 warrants to purchase shares of common stock of the Company, for an aggregate of 11,000,000 newly issued shares of common stock of the Company.

 

3

 

 

On April 22, 2019, the Company entered into an exchange agreement with Alneil. Pursuant to the exchange agreement, Alneil exchanged a convertible debenture of the Company, in the original principal amount of $180,000, and 300,000 warrants to purchase shares of common stock of the Company, for an aggregate of 3,000,000 newly issued shares of common stock of the Company.

 

On October 3, 2019, the Company entered into a letter agreement with Niquana Noel, the Company’s chief executive officer. Pursuant to the agreement, Ms. Noel exchanged $24,000 in accrued but unpaid compensation owed to her by the Company for one share of newly created Series B Preferred Stock of the Company.

 

On March 25, 2020, the Company entered into a letter agreement with Niquana Noel. Pursuant to the agreement, Ms. Noel exchanged one share of Series B Preferred Stock of the Company for one share of newly created Series C Preferred Stock of the Company.

 

On April 20, 2020, the Company entered into a letter agreement with Niquana Noel. Pursuant to the letter agreement, Ms. Noel waived any and all accrued but unpaid compensation owed to her in exchange for the right to retain all 20,000,000 shares of common stock of the Company Ms. Noel had acquired upon exercise of warrants, notwithstanding provisions of the warrant agreement that would have required her to return certain shares to the Company in the event of her resignation. 

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Securities Exchange Act of 1934, as amended, requires the Company’s officers and directors, and certain persons who own more than 10% of a registered class of the Company’s equity securities (collectively, “Reporting Persons”), to file reports of ownership and changes in ownership (“Section 16 Reports”) with the Securities and Exchange Commission (the “SEC”). Based solely on its review of the copies of such Section 16 Reports received by the Company, all Section 16(a) filing requirements applicable to the Company’s Reporting Persons during and with respect to the fiscal year ended August 31, 2019 have been complied with on a timely basis, except that a Form 3 was not filed by McGlothlin Holdings, Ltd.

 

CORPORATE GOVERNANCE

 

Director Independence

 

We do not have any independent directors.

 

Board of Directors’ Meetings

 

During the fiscal year ended August 31, 2019, our Board did not hold any meetings but adopted resolutions pursuant to written consents. We encourage, but do not require, our Board members to attend the annual meeting of shareholders.

 

Board Committees

 

We have not established any committees of the board of directors due to the small size of the Company and the board. We do not have an audit committee financial expert because we do not have the resources to retain one.

 

Board Leadership Structure and Role on Risk Oversight

  

Ms. Noel is presently the only board member.

 

Our board is primarily responsible for overseeing our risk management processes. The board receives and reviews periodic reports from management, auditors, legal counsel, and others, as considered appropriate regarding the Company’s assessment of risks. The board focuses on the most significant risks facing the Company and the Company’s general risk management strategy, and also ensures that risks undertaken by the Company are consistent with the board’s appetite for risk. While the board oversees the Company’s risk management, management is responsible for day-to-day risk management processes. We believe this division of responsibilities is the most effective approach for addressing the risks facing the Company and that our board leadership structure supports this approach.  

 

4

 

 

Stockholder Communication with the Board of Directors

 

Stockholders may send communications to our Board of Directors by writing to Bespoke Extracts, Inc., 323 Sunny Isles Blvd., Suite 700, Sunny Isles, Florida, 33160, Attention: Corporate Secretary.

 

COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS

 

The following table summarizes all compensation to our chief executive officer during the years ended August 31, 2019 and August 31, 2018. No other officer received compensation of more than $100,000 during such periods.

 

Name and Principal Position   Year     Salary     Bonus     Stock
Awards
    Option
Awards
    Non-Equity
Incentive
Plan
Compensation
    Nonqualified
Deferred
Compensation
Earnings
    All Other
Compensation
    Total  
(a)   (b)     (c)     (d)     (e)     (f)     (g)     (h)     (i)     (j)  
Marc Yahr     2019               --       --     $ 0     --       --       --     $ 0  
Former CEO, President (1)     2018     $ 19,000       --       --     $ 3,633,532 (3)             --       --     $ 3,652,532  
                                                                         
Niquana Noel     2019     $ 80,000                     $ 542,390 (4)                           $ 622,390  
Former CEO and President (2)     2018               --       --       --       --       --       --       --  

 

(1) Mr. Yahr resigned as president and chief executive officer of the Company on October 30, 2018.

 

(2) Ms. Noel was appointed as president and chief executive officer of the Company on October 30, 2018.

 

(3)

Represents warrants issued to Marc Yahr under his employment agreement. See Note 5 to the financial statements included in the Company’s annual report for the year ended August 31, 2019. The value attributable to any option awards is computed in accordance with FASB ASC Topic 718. The assumptions made in the valuations of the option awards are included in Note 5 of the notes to the financial statements included in the Company’ annual report for the year ended August 31, 2019.

 

(4) Represents warrants issued to Niquana Noel under her employment agreement. See Note 5 to the financial statements included in the Company’s annual report for the year ended August 31, 2019. The value attributable to any option awards is computed in accordance with FASB ASC Topic 718. The assumptions made in the valuations of the option awards are included in Note 5 of the notes to the financial statements included in the Company’s annual report for the year ended August 31, 2019.

  

Employment Agreements

 

Effective October 30, 2018, the Company entered into an employment agreement with Ms. Noel pursuant to which Ms. Noel served as the Company’s chief executive officer and president. Pursuant to the terms of the employment agreement, Ms. Noel’s salary was $96,000 per year and she received warrants to purchase up to 20,000,000 shares of the Company’s common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrants and was issued the shares. On April 20, 2020, the Company entered into a letter agreement with Ms. Noel. Pursuant to the letter agreement, Ms. Noel waived any and all accrued but unpaid compensation owed to her in exchange for the right to retain all 20,000,000 shares of common stock of the Company Ms. Noel had acquired upon exercise of warrants, notwithstanding provisions of the warrant agreement that would have required her to return certain shares to the Company in the event of her resignation.

 

5

 

 

On April 21, 2020, the Company entered into an employment agreement with Danil Pollack. Pursuant to the employment agreement, Mr. Pollack will serve as the Company’s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share.

 

Outstanding Equity Awards at Fiscal Year-End

 

None.

 

Compensation of Directors

 

No director of the Company received any compensation for serving as director of the Company during the year ended August 31, 2019.

 

WHERE YOU CAN FIND ADDITIONAL INFORMATION

 

We are required to file periodic reports, proxy statements and other information with the SEC. You may read and copy this information by accessing the SEC’s website at http://www.sec.gov. You may also send communications to our Board of Directors at Bespoke Extracts, Inc., 323 Sunny Isles Blvd., Suite 700, Sunny Isles, Florida, 33160, Attention: Corporate Secretary.

 

NO STOCKHOLDER ACTION REQUIRED

 

This Information Statement is being provided for informational purposes only, and does not relate to any meeting of stockholders. Neither applicable securities laws, nor the corporate laws of the State of Nevada require approval of the any transaction referred to herein. No vote or other action is being requested of the Company’s stockholders. This Information Statement is provided for informational purposes only. This Information Statement has been filed with the Securities and Exchange Commission and is available electronically on EDGAR at www.sec.gov.

  

6

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Company has duly caused this Information Statement to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 1, 2020

 

  BESPOKE EXTRACTS, INC.
     
  By: /s/ Danil Pollack
    Danil Pollack
    Chief Executive Officer

  

7

 

 

Bespoke Extracts (QB) (USOTC:BSPK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bespoke Extracts (QB) Charts.
Bespoke Extracts (QB) (USOTC:BSPK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bespoke Extracts (QB) Charts.